Clinical experience with MultiHance in CNS imaging.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15015875.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The use of Gd-BOPTA as a contrast agent for morphological and functional MR imaging allows improved detection and delineation of CNS lesions compared with conventional gadolinium agents. This not only leads to more confident diagnoses being made, but also results in a substantially improved differential diagnostic process. The higher relaxivity of Gd-BOPTA helps to optimize functional MR imaging studies, for example, perfusion MR imaging and dynamic MR angiographic protocols.
Medical subject headings
- Central Nervous System Diseases
- Contrast Media
- Magnetic Resonance Imaging
- Meglumine
- Organometallic Compounds